STUDIES THAT HAVE BEEN COMPLETED BY BWB

Peer-Reviewed Research and Publications:

"Neurotherapy of attention deficit/hyperactivity symptoms [Summary]." Esty ML and Nelson D. The Journal of Neuropsychiatry and Clinical Neurosciences, 22:14,2011. Poster presented at the 22nd Annual Meeting of the American Neuropsychiatric Association, Denver,CO, March 2011. VIEW ABSTRACT HERE

"Neurotherapy of TBI/PTSD in OEF/OIF Veterans." Esty ML and Nelson D. The Journal of Neuropsychiatry and Clinical Neurosciences, 21:221-223, 2009. VIEW ABSTRACT HERE

"Neurotherapy for Chronic TBI/PTSD Symptoms in Vietnam Veterans." Nelson, D and Esty, ML. The Journal of Head Trauma Rehabilitation, (24)5, 403, 2009. VIEW ABSTRACT HERE

"Neurotherapy for pain in veterans with trauma spectrum disorders." Nelson, D and Esty, ML. The Journal of Pain, 10:S18, 2009. VIEW ABSTRACT HERE

"Flexyx Neurotherapy System in the Treatment of Traumatic Brain Injury: An Initial Evaluation." Schoenberger, N., Shiflett, S., Esty, M.L. et al. The Journal of Head Trauma Rehabilitation. Vol.16, # 3. pp. 260 - 274. June , 2001. The 2001 NIH-funded wait-list controlled pilot study of FNS treatment for TBI, documented significant positive change over 25 half-hour treatments, and at 3-month follow up. Dr. Mary Lee Esty conducted this study at the Neurotherapy Center of Washington (NCW) in cooperation with the Kessler Medical Rehabilitation Research and Education Corporation, West Orange, NJ. (Schoenberger et al., 2001) The results demonstrated that FNS is “a promising new treatment for TBI.” Twelve participants were selected on the basis of having no expectation of any substantial improvement in functioning, either from the passage of time or further rehabilitation. Nine were classified as mild TBI and three as moderate TBI. The range of LOC was from 1 minute to 27 days, with TBI events occurring between three and 21 years pre-treatment. Inpatient and outpatient rehabilitations had been completed. Quality of life, social, and economic benefits of FNS treatment were evident in that several returned to work at their pre-trauma level of functioning, six with full-time jobs, and the seventh in a university administrative post with a reduced load. The findings of this study have important implications for those with chronic headache, Fibromyalgia (FM), or moderate cognitive problems of short-term memory, fatigue, and depression, all potentially symptoms from TBI. The changes in the study participants that also had a diagnosis of FM or other pain led directly to an unsolicited grant for the FM study with the Rush, Presbyterian, St-Luke’s Medical Center, Chicago, IL. VIEW THE ARTICLE HERE

"Treatment of Fibromyalgia Syndrome using Low-Intensity Neurofeedback with the Flexyx Neurotherapy System: A Randomized Controlled Clinical Trial." Kravitz, H.M., Esty, M.L., Katz, R.S. & Fawcett, J. The Journal of Neurotherapy. Vol.10, #2/3. pp. 41 - 58. 2006. VIEW THE ARTICLE HERE

"Reflections on FMS Treatment, Research, and Neurotherapy: Cautionary Tales." Esty, M.L. The Journal of Neurotherapy. Vol.10, #2/3. pp. 63 - 68. 2006. VIEW THE ARTICLE HERE